Humira - European Medicines Agency
30 Churchill Place Canary Wharf London E14 5EU United Kingdom An Agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website European Medicines Agency , 2017. Reproduction is authorised provided the source is acknowledged. EMA/518634/2017 EMEA/H/C/000481 EPAR summary for the public Humira adalimumab This is a summary of the European public assessment report (EPAR) for Humira . It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Humira . For practical information about using Humira , patients should read the package leaflet or contact their doctor or pharmacist.
Humira EMA/518634/2017 Page 2/4 Humira is mostly used in adults when their conditions are severe, moderately severe or getting worse, or when patients cannot use other treatments .
Link to this page: